Page 2 - Nsclc Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nsclc management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nsclc Management Today - Breaking & Trending Today

Durvalumab Confirmed Beneficial After NSCLC Chemoradiotherapy

This analysis evaluated patient-related outcomes between those who did and did not receive consolidation durvalumab after chemoradiotherapy for unresectable stage III non–small cell lung cancer.
....

United States , Shawm Durvalulmab , Us Flatiron Health , Eastern Cooperative Oncology Group , Image Credit , American Journal ,

Definitive Therapy Ups Survival in Brain-Only Mets NSCLC

Definitive treatment to the primary site improves overall and cancer-specific survival among patients with brain-only NSCLC metastases, a recent retrospective study shows. ....

Royal Oak , United States , Kamran Salari , Corewell Health East William Beaumont University Hospital , American Society Of Radiation Oncology , American Society , Radiation Oncology , Lung Cancer , Ung Carcinoma , Ancer Of The Lung , Non Small Cell Lung Cancer , Malignant Head And Neck Neoplasm , Head And Neck Cancer , Ead And Neck Cancer Hnc , Brain Metastasis , Metastatic Brain Tumor , Etastatic Disease To The Brain , Rain Metastases Metastatic Brain Tumour , Etastatic Carcinoma , Metastatic Cancer , Small Cell Lung Cancer , Small Cell Lung Cancer ,

Frontline Amivantamab Plus Chemo Receives Positive EU CHMP Opinion for EGFR Exon 20 Insertion+ NSCLC

Frontline amivantamab with chemotherapy has been recommended for approval by the CHMP in EGFR exon 20 insertion+ non–small cell lung cancer. ....

Saint Quentin , Champagne Ardenne , France General , Henar Hevia , Kiran Patel , Nicolas Girard , Institut Curie , Curie Montsouris Thorax Institute , Clinical Development , Johnson Research Development , Versailles Saint Quentin University , European Medicines Agency , Medicinal Products , Human Use , Area Lead , Johnson Innovative Medicine , Solid Tumours , Johnson Research , Lung Cancer , Egfr Exon 20 Insertion Non Small Cell Lung Cancer , The European Medicines Agencys Committee For Medicinal Products Human Use Chmp , Phase 3 Papillon Study Nct04538664 ,

Role of ADCs in HER2-Mutated NSCLC

The panel discusses the role of antibody-drug conjugates (ADCs) and the treatment of patients with HER2 non–small cell lung cancer. ....

Evolving Treatment Landscape , Non Small Cell Lung Cancer , Her2 Nsclc , Her2 Non Small Cell Lung Cancer , Her2 Mutated Nsclc , Antibody Drug Conjugates , Treatment Guidelines , Trastuzumab Deruxtecan ,

Is Osimertinib Better Alone or With Chemotherapy in NSCLC?

A new study reveals that baseline EGFR mutations may be key to making the decision in the frontline setting. ....

United States , University Of Chicago , Dana Farber Cancer Institute , San Diego , Marina Garassino , Clinical Research Annual Meeting , American Association , Drug Administration , American Association For Clinical Research Annual , Pasi Janne , Lung Cancer , Ung Carcinoma , Ancer Of The Lung , Non Small Cell Lung Cancer , Genomics Genomic Medicine , Small Cell Lung Cancer , Small Cell Lung Cancer , At Cell Lung Cancer , Alignant Neoplasia , Alignant Neoplasm , Malignant Head And Neck Neoplasm , Head And Neck Cancer , Ead And Neck Cancer Hnc ,